Genetic Generalized Epilepsy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-10-15
Clinical Trial Update: A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures [Phase 2]
This Phase 2 study compares NPT 2042 to placebo in patients aged 16-75 years with genetic generalized epilepsy and absence seizures and is c…